Shots:

• The research team has presented results of a new multi-biomarker panel candidate with high accuracy (95%) for the diagnosis of stage 1 to 3 high-grade serous ovarian cancer
• The results were included as 16 papers listed supplementary cover articles in the Sep issue of the international scientific journal, Journal of Proteome Research
• As a result of developing and evaluating a predictive model, the accuracy of the diagnostic value for stages 1 to 3 HGSOC was 95% (sensitivity 100%, specificity 91%) when 18 candidate proteins were combined with multiple biomarkers that were identified after quantifying 1,847 serum proteins, through Bertis’ advanced proteomics analysis technology

Ref: Businesswire | Image: Bertis